Moonwalk Biosciences, Inc.
Monday, June 03, 2024
Cell and Gene Therapy and Genome Editing
Company Presentation Theater 1
Moonwalk's novel platform technology provides a complete view of the epigenome in health and disease, with the most advanced AI prediction of epigenetic targets, and the broadest set of epigenetic engineering tools. The company was co-founded by Alex Aravanis, M.D., Ph.D., former CTO of Illumina, world-renowned scientist Feng Zhang, Ph.D. of the Broad Institute of MIT and Harvard, and a distinguished set of industry leaders and company builders. Moonwalk launched in January 2024 with $57 million raised led by Alpha Wave Ventures, and joined by other leading life sciences investors ARCH Venture Partners, Future Ventures, GV, Khosla Ventures and YK Bioventures.
Company Website:
https://moonwalk.bio/
Lead Product in Development:
Not disclosed
Number Of Unlicensed Products (For Which You Are Seeking Partners):
We seek partners for our unique epigenetic read & write platform technology.
Company HQ City
South San Francisco
Company HQ State
CA
Company HQ Country
United States
CEO/Top Company Official
Alex Aravanis
Development Phase of Primary Product
Discovery
Primary Speaker
.jpg)
)
)
)
)
)
)
){kind=logo}
){kind=logo}
.png/fit-in/500x500/filters:no_upscale())